Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients

• Elisabet Matas ,

  * E-mail: ematas@bellvitgehospital.cat

  Affiliation Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯
• Laura Bau,

  Affiliation Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯
• María Martínez-Iniesta,

  Affiliation Translational Research Laboratory, Institut Català d'Oncologia- IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯
• Lucía Romero-Pinel,

  Affiliation Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯
• M. Alba Mañé,

  Affiliations Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, Department of Neurology, Joan XXIII University Hospital, Universitat Rovira I Virgili, Tarragona, Spain

  ⨯
• Álvaro Cobo-Calvo,

  Affiliation Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯
• Sergio Martínez-Yélamos

  Affiliation Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

  ⨯